CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

by Michael C. Burger, Michael C. Burger, Michael C. Burger, Michael C. Burger, Congcong Zhang, Congcong Zhang, Congcong Zhang, Patrick N. Harter, Patrick N. Harter, Patrick N. Harter, Patrick N. Harter, Annette Romanski, Florian Strassheimer, Florian Strassheimer, Christian Senft, Christian Senft, Christian Senft, Torsten Tonn, Torsten Tonn, Torsten Tonn, Torsten Tonn, Joachim P. Steinbach, Joachim P. Steinbach, Joachim P. Steinbach, Joachim P. Steinbach, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels
Published 2019-11-01

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death

by Anna-Luisa Luger, Nadja I. Lorenz, Hans Urban, Iris Divé, Anna L. Engel, Florian Strassheimer, Katja Dettmer, Pia S. Zeiner, Shabnam Shaid, Nina Struve, Malte Kriegs, Ute Hofmann, Peter J. Oefner, Patrick N. Harter, Joachim P. Steinbach, Michael W. Ronellenfitsch
Published 2020-08-01